LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Aclarion (NASDAQ: ACON)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ACON Aclarion
Ness Brent / director, officer: Chief Executive Officer
11/26/2025
Buy
$6.20
10
$62
11